Company Eurocine Vaccines AB Nasdaq Stockholm
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hans Arwidsson
CEO | Chief Executive Officer | 66 | 03-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 86 | 11-12-31 | |
Hans Arwidsson
CEO | Chief Executive Officer | 66 | 03-12-31 |
Pär Thuresson
BRD | Director/Board Member | 64 | 03-12-31 |
Chairman | 61 | 12-12-31 | |
Director/Board Member | - | - | |
Director/Board Member | - | 22-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 344,410,497 | 14,351,490 ( 4.167 %) | 0 | 4.167 % |
Company contact information
Eurocine Vaccines AB
Nanna Svartz väg 4
171 65, Solna
+46 7 06 34 01 71
http://www.eurocine-vaccines.comSector
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- EUCI Stock
- Stock
- Company Eurocine Vaccines AB